visiongain Logo.png
Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain Reports Ltd
14 mars 2023 10h49 HE | Visiongain Reports Ltd
Visiongain has published a new report: Human Microbiome Market, (COVID-19 Impact Analysis):- Market Segment by Product (Prebiotics, Medical Drugs, Diagnostic Tests & Skin Products ), Market...
22157.jpg
State of the Biopharmaceutical Industry 2023: Emerging Technologies, Industry Trends, Regulatory Trends, and Microeconomic Factors
09 mars 2023 11h38 HE | Research and Markets
Dublin, March 09, 2023 (GLOBE NEWSWIRE) -- The "State of the Biopharmaceutical Industry 2023" report has been added to ResearchAndMarkets.com's offering.This report examines the business...
Global Microbiome Sample Preparation Technology Market
Microbiome Sample Preparation Technology Market Report 2022: Rising Penetration of Personalized Medicine Presents Opportunities
01 mars 2023 04h43 HE | Research and Markets
Dublin, March 01, 2023 (GLOBE NEWSWIRE) -- The "Microbiome Sample Preparation Technology Market Size, Share & Trends Analysis Report by Product (Instruments, Consumables), by Workflow, by...
Global Microbiome Therapeutics Market
Microbiome Therapeutics Global Market Research Report 2023
09 févr. 2023 07h43 HE | Research and Markets
Dublin, Feb. 09, 2023 (GLOBE NEWSWIRE) -- The "Microbiome Therapeutics: Global Markets" report has been added to ResearchAndMarkets.com's offering. The global Microbiome Therapeutics market is...
Webinar Presenter
Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders - A Free Webinar from the Brain & Behavior Research Foundation
08 févr. 2023 13h23 HE | Brain & Behavior Research Foundation
New York, Feb. 08, 2023 (GLOBE NEWSWIRE) -- The Brain & Behavior Research Foundation (BBRF) is hosting a free webinar, “Therapeutic Targeting of the Microbiome for Neurodevelopmental Disorders”...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals to Present at the 2023 OBIO Investment Summit on February 10, 2023
07 févr. 2023 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that it has...
visiongain Logo.png
Human Microbiome market is projected to grow at a CAGR of 25.0% by 2033: Visiongain Reports Ltd
02 févr. 2023 06h00 HE | Visiongain Reports Ltd
Visiongain has published a new report: Human Microbiome Market, (COVID-19 Impact Analysis):- Market Segment by Product (Prebiotics, Medical Drugs, Diagnostic Tests & Skin Products ), Market...
Rayont-logo.png
Rayont Inc- RAYT- Reports 10-Q for the Three -Month Ending September 30, 2022, Financial Results.
17 janv. 2023 09h00 HE | Rayont Inc
Palo Alto, California, Jan. 17, 2023 (GLOBE NEWSWIRE) -- Rayont Inc. (“Rayont” or the “Company”) (OTC PINK: RAYT), an international personalized natural healthcare company, today reported financial...
Derm-Biome-Pharmaceuticals.png
Derm-Biome Pharmaceuticals’ Multi-Target Topical Drug Produces Positive Results in Preclinical Study in Acne
09 janv. 2023 10h00 HE | Derm-Biome Pharmaceuticals, Inc
VANCOUVER, British Columbia, Jan. 09, 2023 (GLOBE NEWSWIRE) -- Derm-Biome Pharmaceuticals, Inc, a Vancouver based biopharmaceutical company focused on skin health, is pleased to announce that in a...
Food Trends for 2023
Food Trends for 2023 Include Wellness Drinks, Gut Health, Confusion Around New Labels and Terminology
04 janv. 2023 10h00 HE | International Food Information Council Foundation
Washington, D.C., Jan. 04, 2023 (GLOBE NEWSWIRE) -- With issues like inflation, supply chain disruptions, technological advancements and changing consumer desires, the food system is experiencing a...